HomeAARD • NASDAQ
add
Aardvark Therapeutics Inc
Previous close
$7.79
Day range
$7.72 - $8.70
Year range
$4.88 - $19.58
Market cap
186.38M USD
Avg Volume
122.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.85M | 160.96% |
Net income | -14.37M | -163.66% |
Net profit margin | — | — |
Earnings per share | -0.66 | — |
EBITDA | -15.84M | -160.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 141.82M | 64.24% |
Total assets | 147.48M | 69.12% |
Total liabilities | 10.55M | 296.17% |
Total equity | 136.92M | — |
Shares outstanding | 21.70M | — |
Price to book | 1.23 | — |
Return on assets | -26.02% | — |
Return on capital | -27.42% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -14.37M | -163.66% |
Cash from operations | -9.84M | -133.55% |
Cash from investing | 9.41M | 10,217.20% |
Cash from financing | -71.00K | -100.09% |
Net change in cash | -506.00K | -100.64% |
Free cash flow | -4.70M | — |
About
Founded
2017
Website
Employees
31
